23andMe is the leading personal genetics company dedicated to helping individuals understand their own genetic information through DNA analysis technologies and web-based interactive tools. The company's Personal Genome Service enables individuals to gain deeper insights into their ancestry and genetic make-up. The vision for 23andMe is to personalize healthcare by making and supporting meaningful discoveries through genetic research.
At 23andMe we believe genetic research tools can and should be used to give us a deeper understanding of the role genes play in our individual lives. By tapping into advances in DNA analysis and offering education, tools, and expertise, we at 23andMe want to help others take a bold, informed step toward self-knowledge. We also hope to promote an open discussion of our values with the broader community, including not just our customers but also experts in science, medicine, and policy.
23andMe provides a service: linking you to your genetic data. It is our job to present it with as much context as we can and offer tools to help you explore. Since it is your data, we give you the option to share with other 23andMe members at basic or extended levels or opt-out of sharing entirely.
Latest funding size
Time since last funding
|New Enterprise Associates, Google, Google Ventures, Mohr Davidow Ventures, Xfund, Genentech, SergeyBrin, Johnson & Johnson Development Corporation, MPM Capital, YuriMilner, AnneWojcicki, National Institutes of Health, Casdin Capital, WuXi Healthcare Ventures, Fidelity Management & Research|